Locations:
Search IconSearch

Research

Mobile mammography
February 17, 2023/Cancer/Research

Researchers Aim to Improve Cancer Outcomes Among People Experiencing Homelessness

Early interventions, improved screening access and tailored support services can help patients navigate cancer care

Novel Therapeutics Clinic
February 10, 2023/Cancer/Research

Novel Therapeutics Clinic Offers Access to Early-Phase Trials for Solid Tumors

Dedicated investigators and clinicians bring expertise in drug development and flexible study design

endometrial cancer
February 8, 2023/Cancer/Research

Not All Stage 1 and 2 Endometrial Cancers are Alike

Retrospective study aims to better stratify risk of disease recurrence

hospice care
January 31, 2023/Cancer/Research

Early Intervention Can Help Patients Benefit from Hospice Care at Home

Timely referral to hospice care reduces emergency room admissions

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

lymphoma
January 27, 2023/Cancer/Research

Pembrolizumab Following Autologous Stem Cell Transplantation Shows Promise in T-Cell Non-Hodgkin’s Lymphoma

62% of patients were progression-free at 18 months post-transplantation

22-CNR-3405922-CQD-Hero-650×450 (1)
January 24, 2023/Cancer/Research

Graft Failure Rates Negligible Between Patients with Haplo-Identical Donors and those with Matched Unrelated Donors Receiving Cyclophosphamide

Study assesses the impact of donor source and post-transplant prophylaxis for patients receiving a hematopoietic cell transplant

melanoma
January 20, 2023/Cancer/Research

Practice-Changing Discovery for Treating BRAFV600-Mutant Melanoma

Immunotherapy is preferred initial treatment for majority of patients

Head and neck cancers
January 16, 2023/Cancer/Research

ASCO Releases New Guidelines for Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers

Recommendations focus on selecting the right biomarkers for the right setting

Breast cancer
January 4, 2023/Cancer/Research

Invasive Lobular Cancer and Invasive Ductal Cancer Require Different Clinical Management

Patients with ER-positive invasive lobular cancer face worse disease-free survival and overall survival

22-CNR-3423058-CQD-Hero-650×450 Dr Moore
December 20, 2022/Cancer/Research

Stopping Hormone Therapy for Pregnancy in Patients with Hormone-Receptor Positive Breast Cancer

First prospective study looks at endocrine therapy interruption in premenopausal patients

BackPage 7 of 26Next

Advertisement

Ad